Percentage calculated from 17 of out 19 patients: one patient died for reasons other than the neurostimulator and in another patient the electrode was removed owing to infection. § [Nikka et al., ...

Occipital nerve stimulation is widely considered to be the first choice neurostimulation procedure for chronic cluster headache. Hypothalamic stimulation is an invasive procedure for drug ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

The global neurostimulation market is on a trajectory of impressive expansion, with projections indicating a rise from USD 6,221.2 million in 2023 to an estimated USD 15,417.4 million by 2033. This ...

Incoming Onward Chair Rob ten Hoedt. [Photo courtesy of Pixium Vision] Onward Medical announced today that it appointed long-time Medtronic executive Rob ten Hoedt as the new chair of its board of ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

The Surgical Equipment Market, valued at USD 35.41 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of 9.74 ...

24, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and ...